Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 41(2022), 6 vom: 28. Juni, Seite 997-999 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ahava, Maarit J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 30.05.2022 Date Revised 16.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10096-022-04448-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340131993 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340131993 | ||
| 003 | DE-627 | ||
| 005 | 20231226004442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10096-022-04448-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1133.xml |
| 035 | |a (DE-627)NLM340131993 | ||
| 035 | |a (NLM)35484359 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ahava, Maarit J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.05.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Jarva, Hanna |e verfasserin |4 aut | |
| 700 | 1 | |a Jääskeläinen, Anne J |e verfasserin |4 aut | |
| 700 | 1 | |a Lappalainen, Maija |e verfasserin |4 aut | |
| 700 | 1 | |a Vapalahti, Olli |e verfasserin |4 aut | |
| 700 | 1 | |a Kurkela, Satu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology |d 1988 |g 41(2022), 6 vom: 28. Juni, Seite 997-999 |w (DE-627)NLM012620742 |x 1435-4373 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2022 |g number:6 |g day:28 |g month:06 |g pages:997-999 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10096-022-04448-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2022 |e 6 |b 28 |c 06 |h 997-999 | ||